Professor Yang Wenying: Diabetes and Metabolic Disease Expert in Beijing

Professor Yang Wenying: Diabetes and Metabolic Disease Expert in Beijing

Professor Yang Wenying: Type 2 Diabetes and Metabolic Disease Specialist

Professor Yang Wenying is a senior endocrinologist, professor, and doctoral supervisor associated with China-Japan Friendship Hospital in Beijing. She is widely recognized for clinical leadership and large-scale research in diabetes epidemiology, type 2 diabetes, insulin resistance, metabolic syndrome, and prevention of diabetes complications.

Her work has helped define the prevalence of diabetes and prediabetes in China and has supported earlier identification, standardized treatment, and long-term cardiovascular and kidney risk reduction.

International patients can learn more about the hospital, medical-record requirements, and care planning in our China-Japan Friendship Hospital international patient guide.

Clinical and Academic Focus

Professor Yang’s principal areas include:

  • type 2 diabetes;
  • prediabetes and early metabolic abnormalities;
  • insulin resistance;
  • metabolic syndrome;
  • obesity-related diabetes;
  • difficult blood-glucose control;
  • cardiovascular and kidney risk reduction;
  • diabetes complications; and
  • second opinions on complex diabetes treatment.

Type 2 Diabetes

Type 2 diabetes develops when the body becomes resistant to insulin and the pancreas can no longer produce enough insulin to maintain normal glucose levels. Genetics, body composition, age, sleep, physical activity, nutrition, medicines, and other health conditions can all contribute.

Treatment should address more than HbA1c. Blood pressure, cholesterol, kidney function, weight, liver health, smoking, eye health, nerve function, and cardiovascular disease all influence the long-term plan.

Medication selection depends on glucose level, risk of low blood sugar, kidney and heart disease, weight goals, liver function, age, pregnancy plans, cost, and patient preference.

Prediabetes

Prediabetes means blood glucose is above the normal range but does not meet diagnostic criteria for diabetes. It increases the risk of future diabetes and cardiovascular disease, but progression is not inevitable.

Evaluation should confirm the abnormality and assess related risks. Lifestyle intervention may include realistic weight management, regular physical activity, improved dietary quality, adequate sleep, and treatment of blood pressure and cholesterol.

Medication may be considered in selected high-risk patients, but it does not replace sustainable lifestyle changes or regular monitoring.

Insulin Resistance and Metabolic Syndrome

Insulin resistance is commonly associated with abdominal obesity, fatty liver disease, high triglycerides, low HDL cholesterol, high blood pressure, and impaired glucose regulation. Together, these findings may be described as metabolic syndrome.

There is no single routine test that fully measures insulin resistance in everyday clinical practice. Diagnosis usually relies on the overall metabolic pattern rather than fasting insulin alone.

Treatment focuses on weight, physical activity, nutrition, sleep, smoking, and appropriate management of glucose, lipids, blood pressure, and liver disease.

Difficult Blood-Glucose Control

When glucose remains high despite treatment, the team should review the diabetes diagnosis, adherence, injection technique, diet, medicines that raise glucose, infection, endocrine disease, sleep, stress, and access to monitoring.

Continuous glucose monitoring can reveal overnight patterns, post-meal spikes, hidden hypoglycemia, and day-to-day variability. Its results should be interpreted with medication timing, meals, activity, and symptoms.

Insulin is an appropriate and sometimes essential treatment, not a sign of personal failure. The regimen should be matched to the patient’s daily life and risk of low blood sugar.

Cardiovascular and Kidney Protection

People with type 2 diabetes have an increased risk of heart attack, stroke, heart failure, and chronic kidney disease. Some glucose-lowering medicines provide cardiovascular or kidney benefits beyond their effect on HbA1c.

Treatment selection should consider established cardiovascular disease, heart failure, urine albumin, kidney filtration, dehydration risk, infections, and other contraindications.

Regular kidney testing should include both estimated filtration rate and urine albumin, because early diabetic kidney disease can occur before filtration declines.

Diabetes Complications

Long-term high glucose can damage the eyes, kidneys, nerves, heart, brain, and blood vessels. Screening may include retinal examination, urine albumin, kidney function, foot and nerve assessment, cardiovascular review, and dental care.

Sudden vision loss, a new foot ulcer, severe hypoglycemia, vomiting with dehydration, chest pain, stroke symptoms, or altered consciousness requires urgent medical attention.

Research and Academic Contributions

Professor Yang led major national studies examining the prevalence of diabetes among adults in China. Her landmark research, published in The New England Journal of Medicine, documented the substantial burden of diabetes and prediabetes and influenced prevention and health-policy discussions.

Population prevalence estimates cannot diagnose an individual patient. Diagnosis still requires validated glucose or HbA1c testing interpreted in the clinical context.

Who May Consider a Consultation?

A consultation with Professor Yang or the China-Japan Friendship Hospital endocrinology team may be worth considering when a patient:

  • has type 2 diabetes that remains difficult to control;
  • has repeated hypoglycemia or large glucose fluctuations;
  • has diabetes with heart, kidney, liver, or weight-related complications;
  • has prediabetes with several high-risk features;
  • needs review of a complex medication or insulin regimen;
  • has conflicting results from glucose, HbA1c, or continuous monitoring;
  • needs a comprehensive complication-prevention plan; or
  • wants a second opinion before a major treatment change.

Medical Records to Prepare

International patients should prepare:

  • a concise medical summary and timeline from diagnosis;
  • fasting glucose, post-meal glucose, and HbA1c trends;
  • continuous glucose monitor or home glucose records;
  • kidney function and urine albumin results;
  • cholesterol, liver-function, and blood-pressure records;
  • eye, nerve, foot, and cardiovascular assessments;
  • weight history and relevant sleep or nutrition evaluations;
  • a complete list of current and previous medicines, doses, response, and side effects;
  • details of severe hypoglycemia or hospital admission; and
  • a clear list of treatment goals and questions.

Patients using insulin should include injection timing, dose, meal pattern, and glucose readings for several representative days.

Planning an International Consultation

Stable patients seeking a second opinion should confirm whether records can be reviewed and whether an in-person examination or repeat testing is required.

Remote medical-record review is subject to physician authorization. Medication and insulin changes should be made only after clinical review, with a plan for monitoring glucose and managing hypoglycemia.

How CMCS Can Assist

CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients with organizing and translating diabetes records, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.

Access to Professor Yang, remote review, testing, or any particular treatment is subject to the doctor’s and hospital’s approval. CMCS does not guarantee appointments, treatment eligibility, or clinical outcomes.

For assistance, contact CMCS:

Important Note

Doctor titles, clinical roles, research activities, treatment availability, and appointment arrangements may change. Patients should confirm current information before travel. This profile is based on publicly available hospital and academic sources and is provided for general information only. It is not individual medical advice and does not replace assessment by a qualified endocrinologist.

0 تعليق

إرسال تعليق